Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation
Journal of Clinical Medicine · 14.02.2024 · 13 (4) · 1087
DOI: 10.3390/jcm13041087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 14.02.2024. Verfasst von Paolo De Simone und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liver Transplant Program, University of Pisa Medical School Hospital, Via Paradisa 2, 56124 Pisa, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In Italy, data on long-term survivors after liver transplantation are lacking. Materials and Methods: We conducted a hybrid design study on a cohort of 359 adult recipients who received transplants between 1996 and 2002 to identify predictors of survival and the prevalence of co-morbidities among long-term survivors.
Results
The actuarial (95% CI) patient survival was 96% (94.6–98.3%), 69% (64.2–73.6%), 55% (49.8–59.9%), 42.8% (37.6–47.8%), and 34% (29.2–38.9%) at 1, 5, 10, 15, and 20 years, respectively. The leading causes of death were hepatitis C virus recurrence (24.6%), extrahepatic malignancies (16.9%), infection (14.4%), and hepatocellular carcinoma recurrence (14.4%). The factors associated with the survival probability were younger donor and recipient ages (p = 0.001 and 0.004, respectively), female recipient sex (p < 0.001), absence of HCV (p < 0.01), absence of HCC (p = 0.001), and absence of diabetes mellitus at one year (p < 0.01). At the latest follow-up, the leading comorbidities were hypertension (53.6%), obesity (18.7%), diabetes mellitus (17.1%), hyperlipidemia (14.7%), chronic kidney dysfunction (14.7%), and extrahepatic malignancies (13.8%), with 73.9% of patients having more than one complication.
Conclusions
Aging with a liver graft is associated with an increased risk of complications and requires ongoing care to reduce the long-term attrition rate resulting from chronic immunosuppression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liver Transplant Program, University of Pisa Medical School Hospital, Via Paradisa 2, 56124 Pisa, Italy.
- Department of Surgical, Medical, Biochemical Pathology and Intensive Care, University of Pisa, Via Savi 20, 56126 Pisa, Italy.
- Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Via Paradisa 2, 56124 Pisa, Italy.
- Department of Pathology, University of Pisa Medical School Hospital, Via Paradisa 2, 56124 Pisa, Italy.
- Internal Medicine and Liver Unit, University Hospital Careggi, Largo Brambilla 3, 50134 Florence, Italy.
- Department of Experimental and Clinical Medicine, University of Florence, Piazza San Marco 4, 50121 Florence, Italy.
ORCID-Profile: Paolo De Simone
Zitieren
APA
De Simone, P., Bronzoni, J., Martinelli, C., Ducci, J., Campani, D., Gitto, S., Marchetti, P., & Biancofiore, G. (2024). Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation. Journal of Clinical Medicine, 13(4), 1087. https://doi.org/10.3390/jcm13041087
Vancouver
De Simone P, Bronzoni J, Martinelli C, Ducci J, Campani D, Gitto S, et al. Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation. Journal of Clinical Medicine. 2024;13(4):1087. doi:10.3390/jcm13041087
BibTeX
@article{DeSimone2024,
author = {De Simone, Paolo and Bronzoni, Jessica and Martinelli, Caterina and Ducci, Juri and Campani, Daniela and Gitto, Stefano and Marchetti, Piero and Biancofiore, Giandomenico},
title = {Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {4},
pages = {1087},
doi = {10.3390/jcm13041087}
}
EUVIMED